References
- Ferrario F, Schiaffino E, Boeri R. Fibrillary and immunotactoid glomerulopathies. Ren Fail. 1998;20(6):801–808
- Sethi S, Theis JD, Vrana JA, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8(6):915–921
- Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993;22(3):367–377
- Czarnecki PG, Lager DJ, Leung N, Dispenzieri A, Cosio FG, Fervenza FC. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int. 2009;75(4):420–427
- Nasr SH, Valeri AM, Cornell LD, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6(4):775–784
- Collins M, Navaneethan SD, Chung M, et al. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008;52(6):1158–1162
- Rosenmann E, Eliakim M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron. 1977;18(5):301–308
- Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63(4):1450–1461
- Kim HJ, Kang SW, Park SJ, Kim TH, Kang MS, Kim YH. Fibrillary glomerulonephritis associated with Behçet’s syndrome. Ren Fail. 2012;34(5):637–639
- Coroneos E, Truong L, Olivero J. Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis. 1997;29(1):132–135
- Ray S, Rouse K, Appis A, Novak R, Haller NA. Fibrillary glomerulonephritis with hepatitis C viral infection and hypocomplementemia. Ren Fail. 2008;30(7):759–762
- Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness. Am J Kidney Dis. 2002;40(3):E9(1–5).
- Boross P, Leusen JH. Mechanisms of action of CD20 antibodies. Am J Cancer Res. 2012;2(6):676–690
- Putney JW. TRP, inositol 1,4,5-trisphosphate receptors, and capacitative calcium entry. Proc Natl Acad Sci USA. 1999;96(26):14669–14671